Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9571 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9433 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9071 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9071 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9007 |
High Similarity |
NPD1549 |
Phase 2 |
0.8929 |
High Similarity |
NPD1510 |
Phase 2 |
0.8919 |
High Similarity |
NPD7411 |
Suspended |
0.8913 |
High Similarity |
NPD1240 |
Approved |
0.8867 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8865 |
High Similarity |
NPD2796 |
Approved |
0.8851 |
High Similarity |
NPD4380 |
Phase 2 |
0.88 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8786 |
High Similarity |
NPD1607 |
Approved |
0.8699 |
High Similarity |
NPD1511 |
Approved |
0.8627 |
High Similarity |
NPD7075 |
Discontinued |
0.8621 |
High Similarity |
NPD3750 |
Approved |
0.8609 |
High Similarity |
NPD6801 |
Discontinued |
0.8581 |
High Similarity |
NPD1512 |
Approved |
0.8553 |
High Similarity |
NPD7819 |
Suspended |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD2801 |
Approved |
0.8506 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8446 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8442 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8425 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8425 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8375 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8278 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8276 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8264 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8239 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8231 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8187 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8141 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8041 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8039 |
Intermediate Similarity |
NPD920 |
Approved |
0.8037 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8013 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7986 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7975 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7973 |
Intermediate Similarity |
NPD6100 |
Approved |
0.795 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7945 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7945 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7908 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7905 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7887 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7881 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7847 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7843 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7829 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7826 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7821 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7801 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7785 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7784 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD943 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7701 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7654 |
Intermediate Similarity |
NPD919 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7639 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7639 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7431 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7379 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7342 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7337 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7305 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7288 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7267 |
Intermediate Similarity |
NPD411 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7226 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD17 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7198 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1613 |
Approved |
0.717 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7168 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7124 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7123 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7118 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7086 |
Intermediate Similarity |
NPD8313 |
Approved |
0.707 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7019 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7019
|
Intermediate Similarity |
NPD4661 |
Approved |